Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving vorinostat together with bortezomib works in
treating patients with advanced soft tissue sarcoma. Vorinostat and bortezomib may stop the
growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving
vorinostat together with bortezomib may kill more tumor cells.